Anti-infectives
When antibiotics were first introduced into widespread clinical use in the 1950s, it was generally believed that bacterial diseases no longer constituted a public health threat. With the emergence of new infectious diseases, the re-emergence of old diseases, and the rise of antibiotic resistance, this early optimism has long since eroded. In this series of articles, we explore important issues relevant to the development and use of anti-infectives, including discussions on new approaches to regain the upper hand over infectious diseases.
2004
May 2004 Vol 2 No 5
THE FUTURE OF ANTI-INFECTIVE PRODUCTS IN ANIMAL HEALTH
Thomas R. Shryock
p425 | doi:10.1038/nrmicro887
PREDICTING THE EVOLUTION OF ANTIBIOTIC RESISTANCE GENES
Barry G. Hall
p430 | doi:10.1038/nrmicro888
April 2004 Vol 2 No 4
ANTIMICROBIAL PHARMACODYNAMICS: CRITICAL INTERACTIONS OF 'BUG AND DRUG'
George L. Drusano
p289 | doi:10.1038/nrmicro862
March 2004 Vol 2 No 3
CONFRONTING BACTERIAL RESISTANCE IN HEALTHCARE SETTINGS: A CRUCIAL ROLE FOR MICROBIOLOGISTS
John E. McGowan & Fred C. Tenover
p251 | doi:10.1038/nrmicro845
February 2004 Vol 2 No 2
POPULATION AND EVOLUTIONARY DYNAMICS OF PHAGE THERAPY
Bruce R. Levin & James J. Bull
p166 | doi:10.1038/nrmicro822
WHAT DOES THE FUTURE HOLD FOR CLINICAL MICROBIOLOGY?
Didier Raoult, Pierre Edouard Fournier & Michel Drancourt
p151 | doi:10.1038/nrmicro820
January 2004 Vol 2 No 1
CAN BETTER PRESCRIBING TURN THE TIDE OF RESISTANCE?
David Livermore
p73 | doi:10.1038/nrmicro798
2003
October 2003 Vol 1 No 1
WHERE WILL NEW ANTIBIOTICS COME FROM?
Christopher Walsh
p65 | doi:10.1038/nrmicro727
© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.
